Skip to main content

Table 1 Baseline patient demographic and clinical characteristics

From: A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire

Characteristic

 

N

772

Age, mean (SD)

58.4 (4.1)

Female, n (%)

478 (62.0)

Race/ethnicity, n (%)

 American Indian/Native Alaskan

7 (0.9)

 Asian/Pacific Islander

18 (2.3)

 Black or African American

30 (3.9)

 White

700 (90.9)

 Other

21 (2.7)

 Hispanic/Latino

35 (4.6)

Married/Living with Partner, n (%)

606 (78.5)

Employment status, n (%)

 Full-time employment

536 (69.9)

 Part-time employment

53 (6.9)

 Not employed/working for pay

28 (3.7)

 Retired

98 (12.8)

 Homemaker

52 (6.8)

Income, n (%)

 Less than $25,000

36 (4.9)

 $25,000 - $49,999

122 (16.7)

 $50,000 - $74,999

167 (22.8)

 $75,000 - $99,999

115 (15.7)

 More than $100,000

292 (39.9)

Any claims-based evidence of HZ treatment

551 (71.4)

 Acyclovir

156 (20.2)

 Famciclovir

44 (5.7)

 Valacyclvir

370 (47.9)

Identification diagnosis code (ICD-9-CM), n (%)

 053.0; Herpes zoster with meningitis

4 (0.5)

 053.1×; Herpes zoster with nervous system complications

247 (32.0)

 053.2×; Herpes zoster with eye complications

178 (23.1)

 053.7×; Herpes zoster with ear complications

14 (1.8)

 053.71; Otitis externa due to herpes zoster

2 (0.3)

 053.79; Other specified herpes zoster complications

12 (1.6)

 053.8; Unspecified herpes zoster complication

9 (1.2)

 053.9; Herpes zoster without mention of complication

572 (74.1)